Parkinson's Disease Diagnosis and Treatment Market Size, Growth and Forecast 2035
According to market projections, the global Parkinson’s disease diagnosis and treatment market is anticipated to reach from USD 8.16 billion in 2026 to USD 17.57 billion by 2035, growing at a CAGR of 8.9% over the next decade. In 2025, medications held the largest revenue share of the Parkinson’s disease diagnosis and treatment market, while North America accounted for 39% of revenue. Asia Pacific is set to grow fastest, with a 7.0% CAGR. Key players include Siemens Healthineers, Abbott, GE, AbbVie, Merck, Pfizer, Teva, Sun Pharma, Novartis, and AbbVie, the former Cerevel Therapeutics.
Last Updated : 08 October 2026
Category: Therapeutic Area
Insight Code: 5142
Format: PDF / PPT / Excel